Estrogen dose required to maintain parathyroid hormone mediated bone gain in osteopenic ovariectomized rats is probably higher than in preventive treatment with estrogen
- 31 October 1995
- Vol. 17 (4) , S329-S334
- https://doi.org/10.1016/8756-3282(95)00310-a
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1–34) and pamidronateJournal of Bone and Mineral Research, 1995
- Sequential treatment of osteopenic ovariectomized rats with parathyroid hormone (1-34) fragment and pamidronateJournal of Bone and Mineral Metabolism, 1994
- Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormoneJournal of Bone and Mineral Research, 1992
- Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormoneJournal of Bone and Mineral Research, 1991
- 17β-Estradiol and Continuous Norethisterone: A Unique Treatment for Established Osteoporosis in Elderly WomenJournal of Clinical Endocrinology & Metabolism, 1990
- Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivoJournal of Bone and Mineral Research, 1989
- Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in ratsBone, 1989
- Increased trabecular bone mass in rats treated with human synthetic parathyroid hormoneMetabolic Bone Disease and Related Research, 1984
- Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.BMJ, 1980
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976